CGON 8-K SEC Filing Analysis

Latest settled — T+5d

CGON ▼ -4.30% at T+5d

NEUTRAL call ✗ call lost -4.30% · α vs SPY -5.38% · entry $61.89 → $59.23

Next anchor: T+20d in 14d

Last close $54.40 (close Jun 8) · -12.10% from $61.89 entry

Entry anchored
May 26, 05:52 AM ET
via Databento tick

T+1d

-1.76%

call -1.76% · α -1.77%

$60.80

settled 14d ago

T+5d

-4.30%

call -4.30% · α -5.38%

$59.23

settled 8d ago

T+20d

—

call — · α —

—

in 14d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

CG Oncology announced the departure of President & COO Ambaw Bellete, effective June 30, 2026, and appointed CEO Arthur Kuan as President in addition to his existing roles. The company has initiated a search for a Chief Commercial Officer. This is a routine executive reorganization with no material financial impact.

Actionable Insight

Monitor the Chief Commercial Officer search and any updates on commercial strategy execution. No immediate trading catalyst from this organizational change.

Key Facts

President & COO Ambaw Bellete agreed to separation effective June 30, 2026
CEO Arthur Kuan appointed as President in addition to his current positions
Company initiated search for a Chief Commercial Officer
Bellete will receive severance benefits per existing employment agreement

Financial Impact

No financial figures disclosed; severance is contractual and routine

Risk Factors

Potential disruption from COO departure during commercial build-out
Key-person concentration risk as CEO adds President role

Market Snapshot

Exchange

Nasdaq

Sector

Biological Products, (No Diagnostic Substances)

Analyst Consensus

95% bullish (21 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001193125-26-237908
Document: 0001193125-26-237908-index-headers.html	0001193125-26-237908
Document: 0001193125-26-237908-index.html	0001193125-26-237908
Document: 0001193125-26-237908.txt	0001193125-26-237908

9 reports for CGON

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for CGON — sortable, filterable
	Type				Now
May 26, 2026 14d ago	8-K NEUTRAL ★ 3/10	$61.89 $59.23	▼ −4.30%	▼ −5.38%	$54.40 (−12.10%)
May 15, 2026 25d ago	Press Release BULLISH ★ 6/10	$66.93 $64.25	▼ −4.00%	▼ −4.97%	$54.40 (−18.72%)
May 8, 2026 4w ago	8-K MIXED ★ 5/10	$69.62 $69.54	▼ −0.12%	▼ −1.59%	$54.40 (−21.86%)
May 8, 2026 4w ago	Press Release NEUTRAL ★ 5/10	$69.62 $69.54	▼ −0.12%	▼ −1.59%	$54.40 (−21.86%)
Apr 24, 2026 6w ago	DEFA14A NEUTRAL ★ 3/10	$66.82 $67.70	▲ +1.32%	▲ +0.92%	$54.40 (−18.59%)
Apr 17, 2026 7w ago	144 NEUTRAL ★ 3/10	$70.40 $66.82	▼ −5.09%	▼ −6.00%	$54.40 (−22.73%)
Apr 13, 2026 8w ago	8-K NEUTRAL ★ 3/10	$67.70 $70.40	▲ +3.99%	▲ +0.69%	$54.40 (−19.65%)
Feb 28, 2026 14w ago	Institutional Cluster BULLISH ★ 6/10	$57.76 $61.29	▲ +6.11%	▲ +7.32%	$54.40 (−5.82%)
Feb 27, 2026 14w ago	Press Release NEUTRAL ★ 5/10	$58.80 $61.88	▲ +5.24%	▲ +7.22%	$54.40 (−7.48%)

US Market Status

Market Closed — Opens in 6h 16m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access